Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjhemonc logo
VJOncology
Logo
  • Home (current)
  • Diseases
    Genitourinary
    Lung
    Head and Neck
    Breast
    Gynecological
    Skin
    View all Diseases
    • Topics
      Treatment
      Early Diagnosis
      Nursing
      Pharmacy
      Supportive Care
      Policy
      View all Topics
      • Conferences
        NCRI
        2019
        ISOPP
        2019
        ESMO
        2019
        EONS
        2019
        ASCO
        2019
        ELCC
        2019
        View all Conferences
        • Features
        • Podcasts
          • About
          • Board
          • News
          • Sign Up
          • Contact

        patients

        2:19
        Determining the top ten research priorities in cancer survivorship
        Galina Velikova
        2:33
        Benefits of the scientist-patient interaction
        Martin Christlieb
        2:04
        Interation between patients and researchers: a synergistic exchange
        Martin Christlieb
        1:16
        The NCRI Living with and Beyond Cancer Initiative
        Galina Velikova
        1:03
        Improving approaches for cancer survivorship
        Galina Velikova
        1:23
        NCRI educational session initiatives
        Elaine Vickers
        1:14
        Making the patient voice heard
        Elaine Vickers
        1:11
        Promoting patient involvement through education
        Elaine Vickers
        1:39
        Uncovering the genomic landscape of prostate cancer
        Joaquin Mateo
        3:24
        Interesting topics presented at ESMO 2017
        Fatima Cardoso
        1:22
        Drug shortages around the world: why communication is key
        Fatima Cardoso
        0:43
        Why should physicians and patients be educated about novel drugs?
        Eric Jonasch
        4:13
        What have we learned from recent clinical trials in early breast cancer treatment?
        Elzbieta Senkus-Konefka
        0:50
        Genomic aberrations in prostate cancer
        Joaquin Mateo
        1:25
        PARP inhibitors: their applications and efficacy against prostate cancer
        Joaquin Mateo
        0:57
        When is the optimal time to use PARP inhibitors in prostate cancer patients?
        Joaquin Mateo
        • 1
        • 2
        • 3
        • Next
        vjoncology logo VJOncology is intended for Healthcare Professionals only

        By choosing to continue, you are confirming that you are a healthcare professional

        VJO needs the contact information you provide to inform you about our latest oncology news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

        Please enter your details if you would like to receive the latest oncology news and updates

        Continue
        Disease channels
        • Genitourinary
        • Lung
        • Head and Neck
        • Breast
        • Gynecological
        • Skin
        • View all
        Join our community

        Keep up-to-date via social media

        Sign up for email updates

        Get great new content delivered to your inbox

        Sign up
        mmp logo

        Magdalen Centre
        The Oxford Science Park
        Oxford OX4 4GA, United Kingdom

        VJOncology logo
        The content of VJOncology is intended for healthcare professionals
        • Cookie Policy
        • Privacy Policy
        • Terms of Use
        • Editorial Policy